TSHA
Taysha Gene Therapies (TSHA) Investor Questions
Review Taysha Gene Therapies (TSHA) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Taysha Gene Therapies
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 48
- Annual revenue
- $9.77M
- Annual net income
- $-109.00M
- Annual free cash flow
- $-93.83M
Taysha Gene Therapies (TSHA) Investor Questions research
Taysha Gene Therapies trades under the ticker TSHA. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review TSHA through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.